Skip to main content

Table 2 The assessment of the risk of bias in each Cohort study using the Newcastle-Ottawa scale

From: Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer

Study

Selection (0-4)

Comparability(0-2)

Outcome (0-3)

Total

REC

SNEC

AE

DO

SC

AF

AO

FU

AFU

Sotelo 2014 [24]

*

*

*

*

-

-

*

*

-

6

Seeberg 2014 [25]

*

*

*

*

-

-

*

*

*

7

Gazzaniga 2013 [26]

-

*

*

*

-

-

*

-

-

4

Aggarwal 2013 [27]

-

*

*

*

-

-

*

*

-

5

Kuboki 2013 [14]

-

*

*

*

-

-

*

*

-

5

Deneve 2013 [13]

-

*

*

*

-

-

*

*

-

5

Sastre 2012 [28]

*

*

*

*

-

-

*

*

-

6

Sato 2012 [29]

*

*

*

*

-

-

*

-

-

5

Papavasiliou 2010 [30]

-

-

*

*

-

-

*

-

-

3

Tol 2010 [31]

*

*

*

*

-

-

*

-

-

5

Hiraiwa 2008 [15]

-

*

*

*

-

-

*

-

-

4

  1. NOTE. REC: representativeness of the exposed cohort; SNEC: selection of the non-exposed cohort; AE: ascertainment of exposure; DO: demonstration that outcome of interest was not present at start of study; SC: study controls for age, sex; AF: study controls for any additional factors (chemoradiotherapy, curative resection); AO: assessment of outcome; FU: follow-up long enough (36M) for outcomes to occur; AFU: adequacy of follow-up of cohorts (≥90%).'*' means that the study is satisfied the item (high quality with no bias), and '-' means that the study is not satisfied the item (low quality with bias); Total: the number of high-quality items (no bias) in each study.